The only platform that connects VA claims from initial decision to final judgment — and shows what actually wins. Search 1,850,000+ BVA decisions, CAVC appeals, 38 CFR regulations, and M21-1 policy with AI-powered analysis.
Paste any BVA decision and get a per-issue breakdown, evidence gap analysis, and a draftable argument outline — grounded in 1.85M+ real cases and government sources.
All data comes directly from official government sources: BVA decisions from va.gov, CAVC docket from the Court's eFiling system, CFR from the Electronic Code of Federal Regulations, and M21 policy from the VA's KnowVA system.
Both. Veterans can understand their own claims. VSOs, accredited agents, and attorneys get deeper research tools including advanced search, AI-powered case analysis, docket tracking, and alerts.
Learn why a veteran's claim for an earlier effective date and higher rating for Type II Diabetes was denied, and how Agent Orange exposure plays a critical role.
This case involves a claim for "accrued benefits" related to a deceased veteran's service. The veteran's estate sought service connection for Type II Diabetes, an effective date earlier than October 13, 2021, and a disability rating higher than 20 percent. The Board of Veterans' Appeals (BVA) denied both requests. For the earlier effective date, the BVA found that the VA only received the veteran's claim for Type II Diabetes on October 13, 2021. There was no record of any earlier formal claim or even an informal communication showing an "intent to file" for this condition before that date. Therefore, the effective date for any granted benefits would be October 13, 2021, not earlier. Regarding the request for a higher disability rating, the BVA determined that the veteran's Type II Diabetes treatment did not include "regulation of activities." Under VA rating rules, this specific criterion is often necessary to qualify for a rating higher than 20 percent for diabetes. Without this evidence, the higher rating was denied. Crucially, the BVA also made a finding that the veteran "was not exposed to toxic herbicide agents during his active duty service." While this finding was explicitly applied to other conditions like kidney, prostate, and eye disorders, it has significant implications for Type II Diabetes. Type II Diabetes is a condition that can be presumptively service-connected for veterans exposed to Agent Orange. If a veteran cannot establish Agent Orange exposure, then the presumption cannot apply, making it harder to link the condition to service, especially for an earlier effective date based on onset.
To successfully claim service connection for Type II Diabetes, especially with an earlier effective date or a higher rating, a veteran's estate or survivors need to build a strong case addressing all potential hurdles. First, for an earlier effective date, it's crucial to establish the earliest possible date the VA was put on notice of the veteran's claim. This means finding any record of an "intent to file" or a formal claim for diabetes that predates the one the BVA used. If no such record exists, the effective date will likely remain tied to the actual claim date. Second, for Type II Diabetes, the most common path to service connection is through the Agent Orange presumption. This case highlights a critical issue: the BVA found the veteran was *not* exposed to Agent Orange. To overcome this, the estate or survivors would need to provide compelling evidence of the veteran's Agent Orange exposure during their active duty service. This could involve detailed service records showing presence in a qualifying location (like Vietnam, specific areas in Thailand, or Blue Water Navy service during certain periods) or lay statements from fellow service members who served with the veteran. If Agent Orange exposure can be established, then the VA *must* presume the diabetes is service-connected, potentially allowing for an earlier effective date based on the onset of the condition. Finally, to secure a rating higher than 20 percent, the estate or survivors must provide medical evidence that clearly demonstrates the severity of the veteran's Type II Diabetes. The BVA specifically noted the lack of "regulation of activities." This means obtaining medical records or a doctor's statement from the veteran's treating physicians explaining how their diabetes management required significant adjustments to their daily routine, beyond just diet and medication. This could include frequent monitoring, specific timing of meals and medications, or limitations on physical activity due to symptoms. A detailed medical opinion linking the severity of the diabetes to the need for "regulation of activities" would be essential.
For Type II Diabetes, establishing Agent Orange exposure is often key to service connection and an earlier effective date, and detailed medical evidence is crucial for a higher disability rating.
Analyze My Denial | Browse All Articles